Jefferies & Co. conserve son opinion neutre 23/01 ZM Astellas reçoit l'approbation de Santé Canada pour Vyloy® (Zolbetuximab) ...

Thank you very much for your attendance on to this Q3 Y-to-D FY '24 Financial Results Announcement Meeting. I'm going to serve as a moderator. I'm ...